TBI

NYSEStock

TrueBlue, Inc.

$3.81+0.04 (+1.20%)

52-Week Range

$3.66
$7.68

Key Stats

Market Cap

P/E Ratio

Dividend Yield

Beta

1.49

Volume

146.4K

Avg Volume

292.9K

Performance

1M

-18.79%

3M

-21.67%

6M

-39.06%

YTD

-14.55%

1Y

-35.51%

3Y

-78.02%

5Y

-83.05%

Price Chart

ETF Exposure

TBI is held by 63 ETFs

ETFFund NameWeight
ITDGiShares LifePath Target Date 2055 ETF0.00%
ITDHiShares LifePath Target Date 2060 ETF0.00%
ITDIiShares LifePath Target Date 2065 ETF0.00%
ITDJiShares LifePath Target Date 2070 ETF0.00%
IWViShares Russell 3000 ETF0.00%
SCHBSchwab U.S. Broad Market ETF0.00%
VCNS.TOVanguard Conservative ETF Portfolio0.00%
VEQT.TOVanguard All-Equity ETF Portfolio0.00%
VRIF.TOVanguard Retirement Income ETF Portfolio0.00%
VTHRVanguard Russell 3000 ETF0.00%
VTIVanguard Total Stock Market ETF0.00%
VUN.TOVanguard U.S. Total Market Index ETF0.00%
VUS.TOVanguard U.S. Total Market Index ETF (CAD-hedged)0.00%
PreviousPage 2 of 2

About TBI ETF Exposure

TrueBlue, Inc. (TBI) is held by 63 exchange-traded funds, making it one of the stocks with significant ETF exposure. The stock currently trades at $3.81. Investors can gain exposure to TBI through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold TBI, sorted by portfolio weight.